{"id":62194,"date":"2025-11-13T01:03:40","date_gmt":"2025-11-13T00:03:40","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\/"},"modified":"2025-11-13T01:03:40","modified_gmt":"2025-11-13T00:03:40","slug":"labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\/","title":{"rendered":"LabGenius Therapeutics Announces Poster Presentation at the ESMO Immuno-Oncology Congress 2025"},"content":{"rendered":"
\n

LONDON–(BUSINESS WIRE)–#AI<\/a>—LabGenius Therapeutics<\/a> (\u201cLabGenius\u201d), a drug discovery company combining artificial intelligence (AI) and high-throughput experimentation to advance next-generation multispecific antibodies for solid tumours, today announced a scientific poster will be presented at the ESMO Immuno-Oncology Congress 2025<\/a>, being held December 10 – 12, 2025, at the Queen Elizabeth II Centre in London, United Kingdom. LabGenius\u2019 presentation will debut the pre-clinical in vivo <\/i>efficacy (>90% tumour growth inhibition) and tolerability data for their lead asset, a highly tumour selective bispecific T-cell engager (TCE).<\/p>\n

<\/a>
<\/a><\/p>\n

\nPoster Presentation Details<\/b><\/p>\n\n\n\n\n\n
\n

\nTitle<\/b><\/p>\n<\/td>\n

\n

\nNovel Selectivity-Enhanced Bispecific T-cell Engager Utilises Avidity to Overcome On-target, Off-tumour Toxicity<\/p>\n<\/td>\n<\/tr>\n

\n

\nDate and time<\/b><\/p>\n<\/td>\n

\n

\nWednesday, December 10, 2025, 08:00 (GMT)<\/p>\n<\/td>\n<\/tr>\n

\n

\nPoster number<\/b><\/p>\n<\/td>\n

\n

\n309P<\/p>\n<\/td>\n<\/tr>\n

\n

\nLocation<\/b><\/p>\n<\/td>\n

\n

\nThe Churchill Room, Queen Elizabeth II Centre, London<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nBispecific TCE Overview<\/b><\/p>\n

\nFor the selected target, LabGenius has developed a selectivity-enhanced TCE. The company\u2019s lead optimisation platform, EVA\u2122<\/b><\/i>, <\/i>was used to discover and concomitantly optimise a TCE with improved killing selectivity, potency, efficacy, and manufacturability. The biological mechanism underlying this enhanced selectivity is based on the principle of avidity. By harnessing avidity-driven selectivity, the optimised TCE can distinguish between healthy and diseased cells based on differential tumour-associated antigen expression.<\/p>\n

\nAbout LabGenius Therapeutics<\/b><\/p>\n

\nLabGenius Therapeutics is a drug discovery company pioneering the discovery of next-generation therapeutic antibodies. The company\u2019s discovery platform, EVA\u2122<\/b><\/i>, integrates several cutting-edge technologies drawn from the fields of artificial intelligence, robotic automation and synthetic biology. LabGenius Therapeutics operates a hybrid business model that includes partnering with biotech and pharmaceutical companies in parallel with pursuing a wholly-owned therapeutic pipeline. For more information, please visit www.labgeniustx.com<\/a>, or connect on LinkedIn<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia: press@labgeni.us<\/a>
Corporate \/ business development: partnerships@labgeni.us<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LONDON–(BUSINESS WIRE)–#AI—LabGenius Therapeutics (\u201cLabGenius\u201d), a drug discovery company combining artificial intelligence (AI) and high-throughput experimentation to advance next-generation multispecific antibodies for solid tumours, today announced a scientific poster will be presented at the ESMO Immuno-Oncology Congress 2025, being held December 10 – 12, 2025, at the Queen Elizabeth II Centre in London, United Kingdom. LabGenius\u2019 … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62194","6":"format-standard","7":"category-industry"},"yoast_head":"\nLabGenius Therapeutics Announces Poster Presentation at the ESMO Immuno-Oncology Congress 2025 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LabGenius Therapeutics Announces Poster Presentation at the ESMO Immuno-Oncology Congress 2025 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LONDON–(BUSINESS WIRE)–#AI—LabGenius Therapeutics (\u201cLabGenius\u201d), a drug discovery company combining artificial intelligence (AI) and high-throughput experimentation to advance next-generation multispecific antibodies for solid tumours, today announced a scientific poster will be presented at the ESMO Immuno-Oncology Congress 2025, being held December 10 – 12, 2025, at the Queen Elizabeth II Centre in London, United Kingdom. LabGenius\u2019 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-13T00:03:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251112292702\/en\/2640215\/22\/LabGenius_Horizontal_Logo_Dark_%282%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"LabGenius Therapeutics Announces Poster Presentation at the ESMO Immuno-Oncology Congress 2025\",\"datePublished\":\"2025-11-13T00:03:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\\\/\"},\"wordCount\":281,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251112292702\\\/en\\\/2640215\\\/22\\\/LabGenius_Horizontal_Logo_Dark_%282%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\\\/\",\"name\":\"LabGenius Therapeutics Announces Poster Presentation at the ESMO Immuno-Oncology Congress 2025 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251112292702\\\/en\\\/2640215\\\/22\\\/LabGenius_Horizontal_Logo_Dark_%282%29.jpg\",\"datePublished\":\"2025-11-13T00:03:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251112292702\\\/en\\\/2640215\\\/22\\\/LabGenius_Horizontal_Logo_Dark_%282%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251112292702\\\/en\\\/2640215\\\/22\\\/LabGenius_Horizontal_Logo_Dark_%282%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LabGenius Therapeutics Announces Poster Presentation at the ESMO Immuno-Oncology Congress 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LabGenius Therapeutics Announces Poster Presentation at the ESMO Immuno-Oncology Congress 2025 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\/","og_locale":"en_US","og_type":"article","og_title":"LabGenius Therapeutics Announces Poster Presentation at the ESMO Immuno-Oncology Congress 2025 - Pharma Trend","og_description":"LONDON–(BUSINESS WIRE)–#AI—LabGenius Therapeutics (\u201cLabGenius\u201d), a drug discovery company combining artificial intelligence (AI) and high-throughput experimentation to advance next-generation multispecific antibodies for solid tumours, today announced a scientific poster will be presented at the ESMO Immuno-Oncology Congress 2025, being held December 10 – 12, 2025, at the Queen Elizabeth II Centre in London, United Kingdom. LabGenius\u2019 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\/","og_site_name":"Pharma Trend","article_published_time":"2025-11-13T00:03:40+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251112292702\/en\/2640215\/22\/LabGenius_Horizontal_Logo_Dark_%282%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"LabGenius Therapeutics Announces Poster Presentation at the ESMO Immuno-Oncology Congress 2025","datePublished":"2025-11-13T00:03:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\/"},"wordCount":281,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251112292702\/en\/2640215\/22\/LabGenius_Horizontal_Logo_Dark_%282%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\/","url":"https:\/\/pharma-trend.com\/en\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\/","name":"LabGenius Therapeutics Announces Poster Presentation at the ESMO Immuno-Oncology Congress 2025 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251112292702\/en\/2640215\/22\/LabGenius_Horizontal_Logo_Dark_%282%29.jpg","datePublished":"2025-11-13T00:03:40+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251112292702\/en\/2640215\/22\/LabGenius_Horizontal_Logo_Dark_%282%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251112292702\/en\/2640215\/22\/LabGenius_Horizontal_Logo_Dark_%282%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/labgenius-therapeutics-announces-poster-presentation-at-the-esmo-immuno-oncology-congress-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"LabGenius Therapeutics Announces Poster Presentation at the ESMO Immuno-Oncology Congress 2025"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62194"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62194\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}